Keywords: targacept, tc-1734, shows, promise, memory, study, usa-based

Targacept's TC-1734 shows promise in memory study

Article | 29 May 2006

Print This

USA-based biopharmaceutical group Targacept says that it has seen positive results from Phase II trials of TC-1734 (AZD3480) in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in